[HTML][HTML] Maternal COVID-19 infection and the fetus: Immunological and neurological perspectives

S Falahi, A Abdoli, A Kenarkoohi - New Microbes and New Infections, 2023 - Elsevier
Immunoneuropsychiatry is an emerging field about the interaction between the immune and
nervous systems. Infection and infection-related inflammation (in addition to genetics and …

Effectiveness of vaccination against SARS-CoV-2 and the need for alternative preventative approaches in immunocompromised individuals: a narrative review of …

TT Tan, HJ Ng, B Young, BA Khan, V Shetty… - Expert Review of …, 2023 - Taylor & Francis
Introduction Vaccination against severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2), including administration of booster doses, continues to be the most effective method …

COVID-19 vaccination among patients receiving maintenance renal replacement therapy: immune response, real-world effectiveness, and implications for the future

N Rouphael, M Bausch-Jurken - The Journal of Infectious …, 2023 - academic.oup.com
Chronic kidney disease affects more than 800 million people worldwide and often
progresses to end-stage renal disease, which requires maintenance dialysis. Patients …

Real‐time impact of COVID‐19 pandemic on cutaneous leishmaniasis case finding and strategic planning, preventive interventions, control and epidemiology in a …

M Shams, A Rashidi, J Mohamadi… - Health science …, 2023 - Wiley Online Library
Abstract Background and Aims Cutaneous leishmaniasis (CL) is a severe parasitic disease
affecting people, mostly in underdeveloped nations. As a zoonotic infection yearly incidence …

[HTML][HTML] COVID-19 Vaccine Antibody Response in a Single-Center Urban Hemodialysis Unit

M He, R Song, Z Shaik, CA Gadegbeku, L Enderle… - Vaccines, 2023 - mdpi.com
Background: The longitudinal response to the COVID-19 vaccines among patients on
hemodialysis with and without prior SARS-CoV-2 infection has not been well characterized …

[HTML][HTML] Vaccination and Nutritional Outcomes of Hemodialysis Patients Infected With SARS-CoV-2

A Villaverde-Núñez, MT Ramírez-López… - Nursing …, 2024 - journals.lww.com
Background Patients on hemodialysis are particularly vulnerable to COVID-19 and may
have a reduced response to vaccination because of a decreased immune response. The …

[HTML][HTML] 18-month longitudinal SARS COV-2 neutralizing antibody dynamics in haemodialysis patients receiving heterologous 3-dose vaccination (AZD-1222-AZD …

RP Karunathilake, RA Kumara, A Karunathilaka… - BMC nephrology, 2024 - Springer
Background Patients with chronic kidney disease on haemodialysis (HD) were given priority
COVID-19 vaccination due to increased disease risk. The immune response to COVID-19 …

B and T cell responses to the 3rd and 4th dose of the BNT162b2 vaccine in dialysis patients

Y Bathish, N Tuvia, E Eshel, T Tal Lange… - Human Vaccines & …, 2024 - Taylor & Francis
Patients on dialysis (PoD) are at high risk of severe morbidity and mortality from COVID-19.
Characterizing long-term vaccine immune responses in these patients will help optimize …

Mitigating Endemic COVID-19 Risks in Patients with Chronic Kidney Disease and Kidney Transplantation: A Narrative Review

BA Khan, K Noppakun, J Bruminhent… - 2024 - preprints.org
Patients with chronic kidney disease (CKD), particularly those with end-stage kidney
disease (ESKD) undergoing dialysis or kidney transplantation, face ongoing challenges in …